Starling Oncology, Inc. Current Assets
Starling Oncology, Inc. (DFPH) had Current Assets of $128.99 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $128.99M.
- 2026-03-31: Assets, Current $116.86M.
- 2025-12-31: Assets, Current $112.75M.
- 2025-09-30: Assets, Current $110.09M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $128.99M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $116.86M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $112.75M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $110.09M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $104.79M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $106.82M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $112.42M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $116.42M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $116.21M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $141.19M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $143.49M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $152.68M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $104.07M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $118.96M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $130.42M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $143.63M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $112.20M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $139.84M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $154.06M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $287.11K 10-Q/A · filed 2021-12-14 | |
| 2021-06-30 | $747.18K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $736.15K 10-Q · filed 2021-05-28 | |
| 2020-12-31 | $29.72M 10-K · filed 2022-03-11 | $1.07M 10-K · filed 2021-03-30 |
| 2020-09-30 | $1.20M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $1.35M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.80M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $25.00K 10-K/A · filed 2021-12-14 |